The potential for
hydroxychloroquine for lupus in treating emerging infectious diseases has sparked interest in its antiviral properties. As scientists explore its ability to interfere with viral replication, the drug could become a valuable tool in the global arsenal against pandemic threats, illustrating the ongoing need for flexible and adaptable therapeutic agents.
